Prophase Labs Inc (PRPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 88 | 678 | 1,094 | 2,365 | 1,736 |
| Marketable Securities | N/A | N/A | 2 | 1 | 58 |
| Receivables | 20,204 | 20,058 | 31,638 | 32,937 | 35,116 |
| Inventories | 1,145 | 1,143 | 3,966 | 3,867 | 3,758 |
| Other current assets | 0 | 6,143 | 0 | 0 | 0 |
| TOTAL | $24,770 | $30,637 | $42,235 | $44,143 | $45,045 |
| Non-Current Assets | |||||
| PPE Net | 6,567 | 7,501 | 13,851 | 15,420 | 12,797 |
| Intangibles | 14,335 | 14,981 | 15,627 | 16,272 | 16,918 |
| Other Non-Current Assets | 4,439 | 10,081 | 20,095 | 17,843 | 15,272 |
| TOTAL | $25,341 | $32,563 | $49,573 | $49,535 | $44,987 |
| Total Assets | $50,111 | $63,200 | $91,808 | $93,678 | $90,032 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3,207 | 2,670 | N/A | 2,381 |
| Accounts payable and accrued liabilities | 15,776 | 13,717 | 15,459 | 16,887 | 11,759 |
| Accrued Expenses | 194 | 182 | 160 | 238 | 276 |
| Other current liabilities | 1,663 | 2,115 | 1,620 | 1,544 | 2,057 |
| TOTAL | $24,052 | $32,134 | $28,698 | $28,012 | $23,907 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,779 | 2,925 | 2,926 | 2,926 |
| Deferred Revenues | 1,600 | 1,698 | 1,647 | 1,821 | 1,630 |
| Other Non-Current Liabilities | 7,529 | 18,559 | 17,246 | 13,407 | 11,490 |
| TOTAL | $10,941 | $23,713 | $24,984 | $21,590 | $21,258 |
| Total Liabilities | $34,993 | $55,847 | $53,682 | $49,602 | $45,165 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,154 | 4,188 | 2,387 | 1,908 | 1,908 |
| Common Shares | 29 | 1 | 18 | 18 | 18 |
| Retained earnings | -54,427 | -58,393 | -24,034 | -17,447 | -11,294 |
| Other shareholders' equity | -321 | -198 | -197 | -198 | -140 |
| TOTAL | $15,118 | $7,353 | $38,126 | $44,076 | $44,867 |
| Total Liabilities And Equity | $50,111 | $63,200 | $91,808 | $93,678 | $90,032 |